Literature DB >> 35739243

Subretinal drusenoid deposits as a biomarker of age-related macular degeneration progression via reduction of the choroidal vascularity index.

Solmaz Abdolrahimzadeh1,2, Mariachiara Di Pippo3, Edoardo Sordi3, Mattia Cusato3, Andrew John Lotery4.   

Abstract

BACKGROUND/
OBJECTIVES: This study aimed to analyse the role of the choroid in early age-related macular degeneration (AMD) by analysing choroidal vascularity index (CVI) in pure cohorts of patients with subretinal drusenoid deposits (SDD) or conventional drusen (CD). SUBJECTS/
METHODS: This was an observational cross-sectional study. Comprehensive ophthalmologic examination and multimodal imaging including fundus photography, autofluorescence, near infrared reflectance, and spectral domain optical coherence tomography (SDOCT) was performed. CVI processing was performed on a foveal horizontal SDOCT scan with binarization using Image J Image software and calculated as the ratio between luminal area (LA) and total area (TA).
RESULTS: Sixty-nine eyes of 69 participants were included; 23 eyes with SDD alone, 22 eyes with CD alone, and 24 control eyes of healthy age-matched subjects. CVI was significantly reduced in the SDD and CD group compared to controls (p = 0.0001). Post-hoc analysis revealed a significant reduction of CVI in the SDD versus the control group (p = 0.0002), in the CD versus the control group (p = 0.001), and in the SDD versus the CD group (p = 0.006). Covariance analysis showed a significant difference of LA (p = 0.033) but no significant difference of TA (p = 0.106) between the three groups. Direct comparison between CD and SDD showed a significant reduction of LA and TA in the SDD group.
CONCLUSIONS: CVI may have prognostic implications in early AMD. SDD is a biomarker of AMD progression and the mechanism for this could be via reduction of the CVI.
© 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Year:  2022        PMID: 35739243     DOI: 10.1038/s41433-022-02134-y

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  35 in total

1.  Retinal and choroidal thickness in early age-related macular degeneration.

Authors:  Ashley Wood; Alison Binns; Tom Margrain; Wolfgang Drexler; Boris Považay; Marieh Esmaeelpour; Nik Sheen
Journal:  Am J Ophthalmol       Date:  2011-12       Impact factor: 5.258

2.  The prevalence of age-related macular degeneration in Italy (PAMDI) study: report 1.

Authors:  Stefano Piermarocchi; Tatiana Segato; Pasquale Scopa; Morena Masetto; Stela Ceca; Fabiano Cavarzeran; Tunde Peto
Journal:  Ophthalmic Epidemiol       Date:  2011-06       Impact factor: 1.648

3.  OPTICAL COHERENCE TOMOGRAPHY EVIDENCE ON THE CORRELATION OF CHOROIDAL THICKNESS AND AGE WITH VASCULARIZED RETINAL LAYERS IN NORMAL EYES.

Authors:  Solmaz Abdolrahimzadeh; Francesco Parisi; Vittorio Scavella; Santi M Recupero
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

4.  Relationship of central choroidal thickness with age-related macular degeneration status.

Authors:  Glenn Yiu; Stephanie J Chiu; Philip A Petrou; Sandra Stinnett; Neeru Sarin; Sina Farsiu; Emily Y Chew; Wai T Wong; Cynthia A Toth
Journal:  Am J Ophthalmol       Date:  2014-12-17       Impact factor: 5.258

5.  Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).

Authors:  Cristina A Augood; Johannes R Vingerling; Paulus T V M de Jong; Usha Chakravarthy; Johan Seland; Gisele Soubrane; Laura Tomazzoli; Fotis Topouzis; Graham Bentham; Mati Rahu; Jesus Vioque; Ian S Young; Astrid E Fletcher
Journal:  Arch Ophthalmol       Date:  2006-04

Review 6.  Structural and molecular changes in the aging choroid: implications for age-related macular degeneration.

Authors:  K R Chirco; E H Sohn; E M Stone; B A Tucker; R F Mullins
Journal:  Eye (Lond)       Date:  2016-10-07       Impact factor: 3.775

Review 7.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

8.  Choroidal thickness in age-related macular degeneration.

Authors:  Jost B Jonas; Tessa M Forster; Philippe Steinmetz; Frank C Schlichtenbrede; Björn C Harder
Journal:  Retina       Date:  2014-06       Impact factor: 4.256

9.  Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future.

Authors:  Johanna M Colijn; Gabriëlle H S Buitendijk; Elena Prokofyeva; Dalila Alves; Maria L Cachulo; Anthony P Khawaja; Audrey Cougnard-Gregoire; Bénédicte M J Merle; Christina Korb; Maja G Erke; Alain Bron; Eleftherios Anastasopoulos; Magda A Meester-Smoor; Tatiana Segato; Stefano Piermarocchi; Paulus T V M de Jong; Johannes R Vingerling; Fotis Topouzis; Catherine Creuzot-Garcher; Geir Bertelsen; Norbert Pfeiffer; Astrid E Fletcher; Paul J Foster; Rufino Silva; Jean-François Korobelnik; Cécile Delcourt; Caroline C W Klaver
Journal:  Ophthalmology       Date:  2017-07-14       Impact factor: 12.079

Review 10.  State of science: Choroidal thickness and systemic health.

Authors:  Kara-Anne Tan; Preeti Gupta; Aniruddha Agarwal; Jay Chhablani; Ching-Yu Cheng; Pearse A Keane; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-03-12       Impact factor: 6.048

View more
  1 in total

Review 1.  Choroidal Vasculature Changes in Age-Related Macular Degeneration: From a Molecular to a Clinical Perspective.

Authors:  Serena Fragiotta; Luca Scuderi; Clemente Maria Iodice; Daria Rullo; Mariachiara Di Pippo; Elisa Maugliani; Solmaz Abdolrahimzadeh
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.